Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of December 2016. The report addresses a procedural matter regarding the Company's Annual Meeting of Shareholders originally scheduled for December 26, 2016.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements or performance data.
Material Changes
No material financial changes are reported. The only material event disclosed is the adjournment of the Annual Meeting of Shareholders due to a lack of quorum.
Outlook, Risks, and Management Commentary
Management has reconvened the Annual Meeting of Shareholders for Monday, January 2, 2017, at 10:00 a.m. (Israel time). The meeting will be held at the Company's offices located at 10 Bareket Street, Petach Tikva, Israel. No specific risks, contingencies, or unusual items are detailed in this filing.
Key Facts for Investor Verification
- The Annual Meeting of Shareholders was adjourned on December 26, 2016, due to lack of quorum.
- The reconvened meeting is scheduled for January 2, 2017.
- This filing contains no financial performance data for the period.